$966M Talc Verdict Rocks J&J as Zantac, NEC, and Depo See Major Shifts

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/64/38/ac/6438ac90-36e5-6f31-a3f7-e0807a2f76a2/mza_3683885434505112308.jpg/600x600bb.jpg

The Jon and Marc Podcast

Jon & Marc

27 episodes

2 days ago

Legal growth insights from Jon, Marc, and the industry's top tier legal & marketing professionals. Two veteran legal marketers, Jon Robinson and Marc Rioux, dive into the business of law, mass torts, and the future of plaintiff-side firms. From marketing strategy and technology to candid conversations with top trial lawyers, marketers, and industry leaders, this podcast unpacks what’s really driving growth and change in the legal world. Honest, practical, and a little irreverent—perfect for attorneys, marketers, and anyone curious about where the business of law is headed.

Marketing

Business

RSS

All content for The Jon and Marc Podcast is the property of Jon & Marc and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Marketing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/44108790/44108790-1760633782007-bfdab07fcb094.jpg

$966M Talc Verdict Rocks J&J as Zantac, NEC, and Depo See Major Shifts

The Jon and Marc Podcast

7 minutes 45 seconds

3 weeks ago

$966M Talc Verdict Rocks J&J as Zantac, NEC, and Depo See Major Shifts

This week’s Tort Talks covers the major rulings and developments shaping the mass tort landscape one week before MTMP:

Talcum Powder: A $966 million verdict against J&J in a California mesothelioma trial raises pressure ahead of the first ovarian cancer bellwether set to begin November 3.

Zantac: Oral arguments at the Second Circuit challenge the MDL’s expert exclusion, a decision that could revive tens of thousands of claims and signal what’s ahead for Tylenol.

NEC: A new case management conference is expected to reset the bellwether schedule after earlier dismissals, with a push for backup cases to maintain trial momentum.

Depo-Provera: Case filings have doubled in just three months as a favorable ruling lets plaintiffs keep claims alive while awaiting the key preemption decision due before Thanksgiving.

👉 Your complete mass tort briefing for the week — in less than 10 minutes.

————————— Contents of this video —————————

00:00 – Intro: Tort Talks with Joe Fantini

00:25 – Talcum Powder: $966M Verdict and Ovarian Cancer Trial Preview

01:39 – Zantac: Second Circuit Oral Arguments and Tylenol Parallel

03:54 – NEC: Case Management Conference and Bellwether Framework

05:33 – Depo-Provera: Doubling Filings and Positive Rulings for Plaintiffs

07:14 – Closing: MTMP Preview and Next Week’s Updates